Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:25 PM
Ignite Modification Date:
2025-12-24 @ 7:25 PM
NCT ID:
NCT01240603
Eligibility Criteria:
* INCLUSION CRITERIA:
Age 2 to 65 years, inclusive
Uncomplicated P. falciparum malaria.
Tympanic temperature greater than or equal to 37.5 degree C or history of fever within the last 24 h.
P. calciparum asexual parasite density 10,000 200,000/microL, Inclusive.
Willingness to allow the storage of blood samples collected as part of the study.
Willingness and ability of the patient/guardians to comply with the protocol for the duration of the study.
EXCLUSION CRITERIA:
Severe malaria: diminished consciousness, respiratory distress, severe prostration, anuria, jaundice, hemoglobinuria, repetitive vomiting, or cessation of eating and drinking.
Non-malaria etiology of febrile illness (e.g., respiratory tract infection) evident on clinical examination.
Hematocrit \< 25 percent
Treatment of present symptoms with an artemisinin compound or artemisinin-based combination therapy within the previous 7 days.
Pregnancy or breastfeeding
History or allergy or known contraindication to artemisinins or piperaquine
Splenectomy.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
1 Year
Study:
NCT01240603
Study Brief:
Protocol Section:
NCT01240603